Edgestream Partners L.P. Purchases 24,819 Shares of Integer Holdings Corporation (NYSE:ITGR)

Edgestream Partners L.P. increased its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 208.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,729 shares of the medical equipment provider's stock after acquiring an additional 24,819 shares during the quarter. Edgestream Partners L.P. owned about 0.11% of Integer worth $4,334,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. Capital Research Global Investors increased its stake in shares of Integer by 16.0% in the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock worth $186,960,000 after acquiring an additional 194,895 shares in the last quarter. Loomis Sayles & Co. L P increased its stake in shares of Integer by 3.8% during the fourth quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock valued at $74,041,000 after purchasing an additional 20,688 shares in the last quarter. Congress Asset Management Co. lifted its holdings in shares of Integer by 4.9% during the first quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider's stock valued at $61,679,000 after purchasing an additional 24,306 shares during the last quarter. Driehaus Capital Management LLC boosted its position in shares of Integer by 5.5% in the 4th quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider's stock worth $59,828,000 after purchasing an additional 23,706 shares in the last quarter. Finally, Northern Trust Corp grew its stake in shares of Integer by 14.2% in the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock worth $55,974,000 after buying an additional 52,556 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Integer

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of the firm's stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $120.56, for a total value of $1,051,283.20. Following the completion of the sale, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. This trade represents a 28.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the transaction, the chief executive officer owned 47,000 shares of the company's stock, valued at $5,788,990. This trade represents a 87.82% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 362,434 shares of company stock worth $44,577,115. Company insiders own 2.16% of the company's stock.

Integer Price Performance

NYSE:ITGR traded down $0.29 on Wednesday, reaching $117.15. 364,528 shares of the company's stock traded hands, compared to its average volume of 389,260. The stock has a 50-day simple moving average of $119.90 and a 200-day simple moving average of $124.77. Integer Holdings Corporation has a 12 month low of $104.93 and a 12 month high of $146.36. The firm has a market cap of $4.09 billion, a PE ratio of 55.52, a P/E/G ratio of 1.03 and a beta of 0.98. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. During the same period in the previous year, the firm posted $1.14 EPS. Integer's revenue for the quarter was up 7.3% compared to the same quarter last year. Equities research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on ITGR shares. Raymond James Financial increased their target price on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, April 25th. Benchmark reduced their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and upped their target price for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Truist Financial set a $150.00 price target on shares of Integer and gave the company a "buy" rating in a research report on Friday, April 25th. Finally, KeyCorp lowered their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Integer has an average rating of "Moderate Buy" and a consensus target price of $145.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.